Why some tumors resist immunotherapy: Blocking miR-25 may help turn 'cold' cancers 'hot'

Immune checkpoint therapy, a type of cancer immunotherapy that helps the immune system recognize and attack tumors, has transformed cancer treatment. While these therapies can produce long-lasting benefits for some patients, many cancers either fail to respond or become resistant over time.